Jean-Philippe Bürckert

Follow

Person

Belmont, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-SARS-Cov-2 antibodies derived from 6nb6
- Patent number 11,053,304
- Issue date Jul 6, 2021
- Centivax, Inc.
- Jacob Glanville
- G01 - MEASURING TESTING
Information Patent Grant
Anti-SARS-Cov-2 antibodies derived from CR3022
- Patent number 11,034,762
- Issue date Jun 15, 2021
- Centivax, Inc.
- Jacob Glanville
- G01 - MEASURING TESTING
Information Patent Grant
Anti-SARS-CoV-2 antibodies derived from 2DD8
- Patent number 11,028,150
- Issue date Jun 8, 2021
- Centivax, Inc.
- Jacob Glanville
- G01 - MEASURING TESTING
Information Patent Grant
Anti-SARS-Cov-2 antibodies derived from 3bgf
- Patent number 11,028,167
- Issue date Jun 8, 2021
- Centivax, Inc.
- Jacob Glanville
- G01 - MEASURING TESTING
Information Patent Grant
Anti-SARS-Cov-2 antibodies derived from 2GHW
- Patent number 11,021,531
- Issue date Jun 1, 2021
- Centivax, Inc.
- Jacob Glanville
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NOVEL SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) BIND...
- Publication number 20250215104
- Publication date Jul 3, 2025
- Walden Biosciences, Inc.
- Jean-Philippe Bürckert
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM CR3022
- Publication number 20240270825
- Publication date Aug 15, 2024
- Centivax, Inc.
- Jacob Glanville
- G01 - MEASURING TESTING
Information Patent Application
ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM 2DD8
- Publication number 20230272051
- Publication date Aug 31, 2023
- Centivax, Inc.
- Jacob Glanville
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED VACCINE COMPOSITIONS AND METHODS FOR MAKING THE SAME
- Publication number 20220088175
- Publication date Mar 24, 2022
- Centivax, Inc.
- Jacob GLANVILLE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...